According to the World Health Organisation, Antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. Sadly, the ROI of antibiotic research is now too low for most pharmaceutical companies to consider. In this week’s free edition of the Debunking Economics podcast Phil Dobbie and Prof Steve Keen talk about the failings of the free-market system and health provision.